In an era where patients increasingly turn to the internet for health information, recent research highlights significant shortcomings in the quality and clarity of online resources regarding artificial intelligence (AI) in cancer care. Presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, this study underscores the necessity for improved patient education materials that outline both the benefits and risks associated with AI technologies in oncology.

The State of Online Information

Researchers from the Abramson Cancer Center and Penn's Perelman School of Medicine evaluated over 300 webpages and videos related to AI in cancer treatment. Their findings reveal a troubling trend: many online resources are not only difficult to read but often fail to convey essential safety information about AI applications in healthcare. The analysis discovered that only about one-third of the reviewed content was deemed high quality, with most materials written at a college reading level, which is far above the recommended 6th to 8th grade level for consumer health information. This gap in accessible information poses a significant concern for patients and caregivers who rely on these resources to understand their treatment options. If patients are presented with complex language and incomplete details, they may struggle to make informed decisions about their care.

Understanding AI's Role in Cancer Treatment

AI is making impressive strides in oncology, from enhancing diagnostic accuracy to personalizing treatment plans. However, the effective integration of AI into cancer care necessitates that patients not only understand how these technologies work but also the potential risks involved. For instance, AI tools can sometimes generate misleading information—referred to as "hallucinations"—which may impact a patient’s understanding of their treatment side effects or overall care plan. Dr. Henry Litt, a senior author of the study, noted that patients frequently inquire about AI outputs, indicating that they are actively engaging with these technologies. While clinicians are accustomed to discussing treatment risks, the potential misinformation stemming from AI tools remains an underexplored aspect of patient education.

The Importance of Clear Communication

The research team highlighted that, despite the growing use of AI in clinical settings, the conversation around its implications for patients is far from comprehensive. Many resources focus on how healthcare providers utilize AI, neglecting the direct impact on patients who may use these technologies to seek answers about their health. Access to clear, concise information becomes crucial in this context. As AI continues to evolve within the healthcare landscape, patient education should not be an afterthought but a priority. The study advocates for the development of high-quality, lay-friendly resources that meet patients where they are, ensuring they can safely navigate the complexities of AI in cancer care.

Empowering Patients Through Better Resources

The findings from this research serve as a clarion call for health systems, cancer centers, and oncology organizations to take action. By creating more accessible resources, these entities can help patients understand both the capabilities and limitations of AI technologies in their cancer care. Establishing standards for readability and content quality will empower patients to make informed decisions about their healthcare. As cancer treatment innovation progresses, there is a pressing need for ongoing dialogue between patients and healthcare providers. Patients should feel encouraged to ask questions and discuss AI-related treatments with their doctors, who can provide personalized insights and clarify any misconceptions arising from online resources.

The Path Forward for AI in Cancer Care

As AI transforms oncology, the intersection of technology and patient engagement becomes increasingly relevant. The research underscores the importance of not only advancing AI capabilities but also ensuring that patients are equipped with the knowledge necessary to utilize these tools effectively. An informed patient is an empowered patient, and by improving the quality of information available online, healthcare providers can foster a more supportive environment for those navigating cancer treatment. The responsibility lies with researchers, healthcare providers, and institutions to prioritize patient education as a core component of AI implementation strategies. In conclusion, while AI holds great promise for revolutionizing cancer care, the current state of online information leaves much to be desired. By addressing these gaps, we can ensure that patients have access to the comprehensive, understandable resources they need to engage with their treatment confidently. For those interested in the latest developments in AI and cancer research, platforms like CureCancerWithAi.com provide valuable insights into ongoing advancements and patient-friendly updates in the field.

Readers who want more plain-language context on AI and oncology can also explore the Cure Cancer With AI blog and learn more about the project.